Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Glaukos Submits PMA For iStent, Second-Generation MIGS Device For Treating Glaucoma

Dec 28 2017

• By Marion Webb

Related Content

Alcon Puts Money Where Mouth Is With Glaucoma Device Buy

Feb 22 2016

Glaukos' Micro-Bypass Stents Work As First-Line Glaucoma Therapy

Sep 26 2016

Glaukos rolls on with direct sales conversion for new-gen iStent

Feb 10 2016

Related Companies

Glaukos Corporation

Allergan plc

Alcon Inc.

Additional Topics

Approvals Companies FDA Commercial Ophthalmology Medical Device

More from Ophthalmology

More from Device Area

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.